Latest Updates of Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com
Antigen Coupler News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Antigen Coupler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Antigen Coupler Today - Breaking & Trending Today
First patient dosed in study of cell therapy for gastric cancer
Triumvira Immunologics, a Texas-based clinical-stage company developing T cell therapeutics to treat patients with solid tumors, has announced that the first patient has been dosed in its phase 2 trial to treat gastric cancer.
Source: biopharma-reporter.com
Latest Updates of 9 Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com
Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual Meeting
/PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the...
Source: prnewswire.com
Triumvira Immunologics to Present Clinical Data from Phase I/II Trial TACTIC-2 Investigating TAC01-HER2 at the 2023 ASCO Annual Meeting
/PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the...
Source: prnewswire.com